Ozer, M. Et Al. 2013. Impact of Genetic Factors (CYP2C9, VKORC1 and CYP4F2) on Warfarin Dose Requirement in the Turkish Population. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY , vol.112, no.3 , 209-214.

Ozer, M., Demirci, Y., Hizel, C., Sarikaya, S., KARALTI, İ., Kaspar, C., ... Alpan, S.(2013). Impact of Genetic Factors (CYP2C9, VKORC1 and CYP4F2) on Warfarin Dose Requirement in the Turkish Population. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY , vol.112, no.3, 209-214.

Ozer, Mahmut Et Al. "Impact of Genetic Factors (CYP2C9, VKORC1 and CYP4F2) on Warfarin Dose Requirement in the Turkish Population," BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY , vol.112, no.3, 209-214, 2013

Ozer, Mahmut Et Al. "Impact of Genetic Factors (CYP2C9, VKORC1 and CYP4F2) on Warfarin Dose Requirement in the Turkish Population." BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY , vol.112, no.3, pp.209-214, 2013

Ozer, M. Et Al. (2013) . "Impact of Genetic Factors (CYP2C9, VKORC1 and CYP4F2) on Warfarin Dose Requirement in the Turkish Population." BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY , vol.112, no.3, pp.209-214.

@article{article, author={Mahmut Ozer Et Al. }, title={Impact of Genetic Factors (CYP2C9, VKORC1 and CYP4F2) on Warfarin Dose Requirement in the Turkish Population}, journal={BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY}, year=2013, pages={209-214} }